The need for an organoid manufacturing, preservation, and distribution center

Anthony Atala; John C Bischof; Christopher S Chen; John P Fisher; David L Hermanson; Charles L Howe; Walter C Low; Zhen Ma; David H McKenna; Sean P Palecek; Johnna S Temenoff; Brenda M Ogle

doi:10.1093/stcltm/szaf031

The need for an organoid manufacturing, preservation, and distribution center

Anthony Atala
, John C Bischof
, Christopher S Chen
, John P Fisher
, David L Hermanson
, Charles L Howe
, Walter C Low
, Zhen Ma
, David H McKenna
, Sean P Palecek
, Johnna S Temenoff
, Brenda M Ogle

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Organoids, which are tiny, lab-grown 3D structures that mimic some organizational and functional properties of human organs, are slowly transforming the face of systems and developmental biology, biomedical research, pharmaceutical testing, environmental toxin testing, and healthcare. Significant investments are essential for the mass production, preservation, and distribution of organoids, with the aim to accelerate innovation and progress across multiple fields-much like the investments made in cell and biologics manufacturing over the past 2 decades.

Original language	English (US)
Article number	szaf031
Journal	Stem Cells Translational Medicine
Volume	14
Issue number	7
DOIs	https://doi.org/10.1093/stcltm/szaf031
State	Published - Jul 1 2025

Bibliographical note

Publisher Copyright:
© 2025 The Author(s).

Keywords

Organoids/cytology
Humans

PubMed: MeSH publication types

Journal Article
Review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1093/stcltm/szaf031

Find It

Find It at U of M Libraries

Cite this

@article{7535e234f9f640bbb93e46a615dad1f2,

title = "The need for an organoid manufacturing, preservation, and distribution center",

abstract = "Organoids, which are tiny, lab-grown 3D structures that mimic some organizational and functional properties of human organs, are slowly transforming the face of systems and developmental biology, biomedical research, pharmaceutical testing, environmental toxin testing, and healthcare. Significant investments are essential for the mass production, preservation, and distribution of organoids, with the aim to accelerate innovation and progress across multiple fields-much like the investments made in cell and biologics manufacturing over the past 2 decades.",

keywords = "Organoids/cytology, Humans",

author = "Anthony Atala and Bischof, \{John C\} and Chen, \{Christopher S\} and Fisher, \{John P\} and Hermanson, \{David L\} and Howe, \{Charles L\} and Low, \{Walter C\} and Zhen Ma and McKenna, \{David H\} and Palecek, \{Sean P\} and Temenoff, \{Johnna S\} and Ogle, \{Brenda M\}",

note = "Publisher Copyright: {\textcopyright} 2025 The Author(s).",

year = "2025",

month = jul,

day = "1",

doi = "10.1093/stcltm/szaf031",

language = "English (US)",

volume = "14",

journal = "Stem Cells Translational Medicine",

issn = "2157-6564",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - The need for an organoid manufacturing, preservation, and distribution center

AU - Atala, Anthony

AU - Bischof, John C

AU - Chen, Christopher S

AU - Fisher, John P

AU - Hermanson, David L

AU - Howe, Charles L

AU - Low, Walter C

AU - Ma, Zhen

AU - McKenna, David H

AU - Palecek, Sean P

AU - Temenoff, Johnna S

AU - Ogle, Brenda M

PY - 2025/7/1

Y1 - 2025/7/1

N2 - Organoids, which are tiny, lab-grown 3D structures that mimic some organizational and functional properties of human organs, are slowly transforming the face of systems and developmental biology, biomedical research, pharmaceutical testing, environmental toxin testing, and healthcare. Significant investments are essential for the mass production, preservation, and distribution of organoids, with the aim to accelerate innovation and progress across multiple fields-much like the investments made in cell and biologics manufacturing over the past 2 decades.

AB - Organoids, which are tiny, lab-grown 3D structures that mimic some organizational and functional properties of human organs, are slowly transforming the face of systems and developmental biology, biomedical research, pharmaceutical testing, environmental toxin testing, and healthcare. Significant investments are essential for the mass production, preservation, and distribution of organoids, with the aim to accelerate innovation and progress across multiple fields-much like the investments made in cell and biologics manufacturing over the past 2 decades.

KW - Organoids/cytology

KW - Humans

UR - https://www.scopus.com/pages/publications/105010609521

UR - https://www.scopus.com/pages/publications/105010609521#tab=citedBy

U2 - 10.1093/stcltm/szaf031

DO - 10.1093/stcltm/szaf031

M3 - Article

C2 - 40627335

SN - 2157-6564

VL - 14

JO - Stem Cells Translational Medicine

JF - Stem Cells Translational Medicine

IS - 7

M1 - szaf031

ER -

The need for an organoid manufacturing, preservation, and distribution center

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

ATP-Bio: NSF Engineering Research Center for Advanced Technologies for the Preservation of Biological Systems (ATP-Bio)

Cite this

The need for an organoid manufacturing, preservation, and distribution center

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Projects

ATP-Bio: NSF Engineering Research Center for Advanced Technologies for the Preservation of Biological Systems (ATP-Bio)

Cite this